Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension.
An infusion of prostacyclin (PGI2) in four patients with pulmonary hypertension resulted in a dose-related decrease in the systemic and pulmonary vascular resistance and an increase in cardiac output. No selectivity for the pulmonary vasculature was observed and the drug was not therapeutically bene...
Sábháilte in:
| Foilsithe in: | Br Heart J |
|---|---|
| Príomhchruthaitheoirí: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMJ Publishing Group
1981
|
| Ábhair: | |
| Rochtain ar líne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC482538/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7013775/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.45.4.385 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|